These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29328640)

  • 21. Relationship between psoriasis and metabolic syndrome: a systematic review.
    Singh S; Young P; Armstrong AW
    G Ital Dermatol Venereol; 2016 Dec; 151(6):663-677. PubMed ID: 27589483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Psoriasis and Metabolic Syndrome in Latin America: A Systematic Review and Meta-Analysis.
    Rodríguez-Zúñiga MJM; Cortez-Franco F; Quijano-Gomero E
    Actas Dermosifiliogr; 2017 May; 108(4):326-334. PubMed ID: 28117050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of metabolic syndrome in patients with psoriasis.
    Nisa N; Qazi MA
    Indian J Dermatol Venereol Leprol; 2010; 76(6):662-5. PubMed ID: 21079309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atheroma plaque, metabolic syndrome and inflammation in patients with psoriasis.
    Arias-Santiago S; Orgaz-Molina J; Castellote-Caballero L; Arrabal-Polo MÁ; García-Rodriguez S; Perandrés-López R; Ruiz JC; Naranjo-Sintes R; Zubiaur M; Sancho J; Buendía-Eisman A
    Eur J Dermatol; 2012; 22(3):337-44. PubMed ID: 22503884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome.
    Feldman RA; O'Neill K; Butts SF; Dokras A
    Fertil Steril; 2017 Jan; 107(1):276-281. PubMed ID: 27842995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome in Spanish patients with psoriasis needing systemic therapy: Prevalence and association with cardiovascular disease in PSO-RISK, a cross-sectional study.
    Belinchón I; Vanaclocha F; de la Cueva-Dobao P; Coto-Segura P; Labandeira J; Herranz P; Taberner R; Juliá B; Cea-Calvo L; Puig L
    J Dermatolog Treat; 2015; 26(4):318-25. PubMed ID: 25362972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Association of Metabolic Syndrome and Psoriasis: A Systematic Review and Meta-Analysis of Observational Study.
    Choudhary S; Pradhan D; Pandey A; Khan MK; Lall R; Ramesh V; Puri P; Jain AK; Thomas G
    Endocr Metab Immune Disord Drug Targets; 2020; 20(5):703-717. PubMed ID: 31595859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of serum uric acid levels in psoriasis vulgaris.
    Yilmaz E; Tamer E; Artüz F; Külcü Çakmak S; Köktürk F
    Turk J Med Sci; 2017 Apr; 47(2):531-534. PubMed ID: 28425242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of cardio-metabolic risk profile in patients with psoriasis.
    Karoli R; Fatima J; Shukla V; Dhillon KS; Khanduri S; Maini S; Chandra A
    J Assoc Physicians India; 2013 Nov; 61(11):798-803. PubMed ID: 24974491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Study on the Association of Psoriasis with Metabolic Disorders.
    Jadhav N; Nadkarni N; Patil S
    J Assoc Physicians India; 2019 Apr; 67(4):52-54. PubMed ID: 31309797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic Syndrome in Adults With Congenital Heart Disease.
    Deen JF; Krieger EV; Slee AE; Arslan A; Arterburn D; Stout KK; Portman MA
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psoriasis Severity and Cardiometabolic Risk Factors in a Representative US National Study.
    Lin IC; Heck JE; Chen L; Feldman SR
    Am J Clin Dermatol; 2021 Sep; 22(5):719-730. PubMed ID: 33913115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study.
    Gisondi P; Tessari G; Conti A; Piaserico S; Schianchi S; Peserico A; Giannetti A; Girolomoni G
    Br J Dermatol; 2007 Jul; 157(1):68-73. PubMed ID: 17553036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of metabolic syndrome in patients with psoriasis at Mostar Clinical Hospital.
    Topić I; Simić D
    Acta Clin Croat; 2013 Mar; 52(1):53-8. PubMed ID: 23837273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are patients with psoriasis susceptible to the classic risk factors for actinic keratoses?
    Paltiel O; Adler B; Herschko K; Tsukrov B; David M
    Arch Dermatol; 2004 Jul; 140(7):805-10. PubMed ID: 15262690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic syndrome in untreated patients with psoriasis: case-control study.
    Damevska K; Neloska L; Gocev G; Mihova M
    J Dtsch Dermatol Ges; 2013 Dec; 11(12):1169-75. PubMed ID: 24267013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Socioeconomic Inequalities and Severity of Plaque Psoriasis at a First Consultation in Dermatology Centers.
    Mahé E; Beauchet A; Reguiai Z; Maccari F; Ruer-Mulard M; Chaby G; Le Guyadec T; Estève E; Goujon-Henry C; Parier J; Barthelemy H; Bégon E; Steiner HG; Bénéton N; Boyé T; Mery-Bossard L; Schmutz JL; Bravard P;
    Acta Derm Venereol; 2017 May; 97(5):632-638. PubMed ID: 28127620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psoriasis and diabetes: a population-based cross-sectional study.
    Cohen AD; Dreiher J; Shapiro Y; Vidavsky L; Vardy DA; Davidovici B; Meyerovitch J
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):585-9. PubMed ID: 18331320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoriasis and the metabolic syndrome.
    Cohen AD; Gilutz H; Henkin Y; Zahger D; Shapiro J; Bonneh DY; Vardy DA
    Acta Derm Venereol; 2007; 87(6):506-9. PubMed ID: 17989888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.